dpp-4 and glp-1 Dipeptidyl Peptidase 4: DPP4 DPP-4 inhibitors and GLP-1RAs: cardiovascular

If a beneficiary does not enroll in Part B when first eligible and lacks other creditable coverage, a late enrollment penalty (10% for each 12-month period of delay) may be added to their premium

Visual latencies in areas V1 and V2 of the macaque monkey

Its important to know that removing stretch marks completely is very challenging, and no topical ingredient or product has been proven to significantly erase them

Bottom Line The Path to $1 Trillion Current State (Nov 2025): Stock Price: ~$990 Market Cap: ~$885-930B Distance to $1T: ~7-13% away Catalysts Ahead: Orforglipron approval (March 2026 expected) Continued GLP-1 market expansion Kisunla (Alzheimer's) adoption ramp Pipeline readouts in oncology and immunology For Long-Term Investors: Volatility is part of the journey